جستجوی استاد راهنمای دانشگاهی

Nida Latif is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine. Her work focuses on understanding coronary microvascular dysfunction and ischemic heart disease in patients with nonobstructive coronary arteries, particularly in women. She is a key contributor to the DISCOVER INOCA multicenter registry, evaluating invasive coronary function testing protocols and diagnostic strategies. Her research integrates clinical, anatomical, and physiological data to improve diagnostic accuracy and patient outcomes. Key areas of investigation include coronary vasoreactivity testing, risk factor analysis in ischemic syndromes, and the impact of diabetes on angina pathophysiology. Latif's publications highlight advancements in coronary flow reserve measurement, comparison of diagnostic modalities (e.g., PET vs thermodilution), and the clinical utility of vessel-specific analysis. Her work emphasizes translational outcomes, bridging basic science insights with clinical practice improvements. While no specific awards are listed, her contributions to high-impact clinical registries and peer-reviewed publications reflect her active role in advancing cardiovascular medicine.

• Cardiovascular Disease
• Coronary Microvascular Dysfunction
• Invasive Coronary Function Testing
• +۳ مورد دیگر

Xiaochen He serves as an Instructor in the Department of Physiology & Biophysics at the University of Mississippi Medical Center's School of Medicine, where he focuses on cardiovascular research and teaching within this foundational medical science department. His research program centers on the intersection of cardiac pathophysiology and immunometabolism, with core interests including: Mechanisms of immune-mediated cardiac inflammation in heart failure Role of T cell subsets (Th17, γδ T, CD8+) in pressure overload models Molecular regulation by IL-12 family cytokines and metabolic enzymes (TIGAR, SIRT3) Endothelial dysfunction in cardiac hypertrophy and failure progression Therapeutic interventions targeting inflammatory pathways Analysis of Dr. He's recent publications (2022-2025) reveals a concentrated research trajectory investigating how specific immune pathways drive heart failure progression. His work consistently employs genetic mouse models to demonstrate that IL-12β inhibition, TIGAR deficiency, and selenium supplementation attenuate cardiac inflammation and dysfunction, while CD8+ T cell metabolic reprogramming exacerbates disease. Key discoveries include GPR174's role in Th17 differentiation and NK1.1 signaling's contribution to cardiopulmonary inflammation, establishing critical immune-metabolic axes in heart failure pathogenesis. No scientific awards were documented in the available profile information. Current departmental records indicate no graduate students are formally listed under Dr. He's mentorship, and no research grants are specified in the public profile. Details regarding laboratory infrastructure, research teams, or collaborative networks were not provided in the available institutional documentation.

• Heart Failure
• Cardiovascular Immunology
• Cardiac Inflammation
• +۳ مورد دیگر

David N. Proctor is a Professor of Kinesiology and Physiology at Pennsylvania State University . His research focuses on human cardiovascular aging, vascular adaptation to exercise, and therapeutic strategies for aging populations.

• Aging
• Cardiovascular Physiology
• Exercise Physiology
• +۵ مورد دیگر

Louise Pilote, MD, MPH, PhD is Professor of Medicine in the Department of Medicine, Division of Internal Medicine , McGill University , and Senior Scientist in the Cardiovascular Health Across the Lifespan Program at the Research Institute of the McGill University Health Centre (RI-MUHC) , Montréal, Canada. Education: Louise Pilote holds the combined degrees of MD, MPH, and PhD, reflecting advanced clinical, public-health and research training that underpins her translational work. Research Focus: Internationally recognized pioneer in sex- and gender-based cardiovascular epidemiology , developing novel gender indices to disentangle biological (sex) and sociocultural (gender) determinants of cardiovascular outcomes. Leads the multinational GOING-FWD consortium (Gender Outcomes International Group to Further Well-being Development), integrating sex/gender analytics across 30 cohorts totaling 30 million patients with chronic diseases. Authority on comparative effectiveness and pharmacoepidemiology leveraging administrative “Big Data”, clinical registries, and advanced biostatistical/machine-learning methodologies. Current clinical-translational projects include imaging-based diagnosis of coronary microvascular dysfunction , a condition disproportionately affecting women. Scientific Impact & Awards: While formal awards are not enumerated in the supplied text, Dr Pilote’s sustained leadership as senior author on major Canadian and international cardiovascular guidelines, her role in founding the GOING-FWD network, and her extensive publication record (398 PubMed-indexed articles, 1988-2025) collectively constitute significant peer recognition. Students & Mentoring: Specific trainee names are not provided in the text; however, as Professor at McGill and Senior Scientist at RI-MUHC she supervises graduate students, clinical research fellows, and post-doctoral researchers in cardiovascular epidemiology, data science, and gender medicine. Laboratories & Teams: Dr Pilote heads the cardiovascular epidemiology research group within the Centre for Outcomes Research and Evaluation (CORE) at RI-MUHC, coordinating a multi-disciplinary team of biostatisticians, data scientists, clinician-scientists, and trainees.

• Cardiovascular Epidemiology
• Sex and Gender Differences in Cardiovascular Disease
• Comparative Effectiveness Research
• +۵ مورد دیگر

Haipeng Liu is an Assistant Professor in the Centre for Intelligent Healthcare at Coventry University. His research focuses on cardiovascular system modeling, biosignal processing, wearable nanosensors, and AI-driven diagnostics. He has supervised over 100 research outputs and holds editorial roles in journals like Frontiers in Physiology and Electronics . His work bridges clinical needs with technological innovation, particularly in healthcare technology and cardiovascular diagnostics. Research Interests: Computational modeling of cardiovascular systems, AI-enhanced diagnostics, wearable sensors, and medical imaging. Key Awards: British Heart Foundation Travel Award (2019), First Prize in National Mathematics Competition (2011). Collaborations: Active in global research networks, including the World Stroke Organization. His recent work emphasizes machine learning applications in cardiology and stroke diagnostics, with publications in Physics of Fluids , European Journal of Radiology , and Frontiers in Genetics . He is a sought-after advisor for PhD students exploring healthcare technology.

• Cardiovascular System Modelling
• Biosignal Processing
• Wearable Nanosensors
• +۵ مورد دیگر

Dr. Keith Oldroyd is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on coronary physiology, myocardial infarction, and interventional cardiology, with a particular emphasis on fractional flow reserve (FFR) and coronary microvascular dysfunction. He leads major clinical trials such as CorMicA and FAMOUS-NSTEMI, assessing diagnostic and therapeutic strategies in coronary artery disease. Key contributions include advancing understanding of coronary microvascular dysfunction, optimizing PCI outcomes, and evaluating the clinical impact of influenza vaccination post-MI. Collaborations with institutions globally highlight interdisciplinary work in drug-eluting stents, biomaterials, and cardiovascular imaging. Over 150 peer-reviewed publications (2001–2024) Principal Investigator for CorMicA trial Leadership in Glasgow PRAMI and EVOLVE 48 studies Labs/Teams: Active in translational cardiology research at the Golden Jubilee National Hospital and University of Glasgow's cardiovascular imaging and intervention teams.

• Cardiovascular Medicine
• Coronary Artery Disease
• Fractional Flow Reserve
• +۶ مورد دیگر

Kazuaki Negishi is a Professor of Medicine and Head of the Discipline of Medicine at Sydney Medical School Nepean, University of Sydney's Faculty of Medicine and Health. He holds adjunct professorships at the University of Tasmania and is a board-certified cardiologist in Japan and Australia. His expertise spans cardio-oncology, air pollution-cardiovascular links, space medicine, and advanced imaging. Clinically, he practices at Nepean Hospital and previously led the Echo lab at Royal Hobart Hospital. He completed his MD and PhD in Japan, with additional training at Cleveland Clinic, USA. Research interests include cardiovascular imaging, subclinical myocardial insults, and health policy. He leads a team of 1 Senior Research Fellow, 2 Post-Doctoral fellows, and supervises PhD students across multiple institutions. Awards include the National Heart Foundation Future Leader Fellowship and international society recognitions (FACC, FESC, FAHA). Key collaborations include NASA, Gunma University (Japan), and the ANZACT Network. His work on SUCCOUR trials and REDUCE trial (sonothrombolysis) aims to improve cardiovascular outcomes in oncology patients. He chairs editorial boards for JACC: Cardiovascular Imaging and Journal of the American Society of Echocardiography .

• Cardio-Oncology
• Air Pollution and Cardiovascular Disease
• Space Medicine
• +۵ مورد دیگر

Adam Goodwill, Ph.D., FCVS is an Assistant Professor in the Department of Integrative Medical Sciences at Northeast Ohio Medical University (NEOMED). He previously served as Assistant Clinical Professor of Anatomy, Cell Biology & Physiology and Director of the Pre-Professional M.S. Program at Indiana University School of Medicine for a decade before relocating to Northeast Ohio in 2021. Ph.D. in Physiology and Pharmacology, West Virginia University School of Medicine (2011) B.S. in Molecular Biology/Biotechnology, Clarion University of Pennsylvania (2003) B.S. in Biology, Clarion University of Pennsylvania (2003) His research focuses on the interplay between myocardial contractile function and coronary blood flow regulation, particularly how oxygen demand and delivery become dysregulated in cardiovascular diseases. The laboratory employs a top-down approach, starting with in vivo models and progressing to molecular analysis, aiming to identify therapeutic targets for cardiovascular disorders. Key research themes from his publications include: Investigation of sodium-glucose cotransporter-2 inhibition in myocardial ischemia GLP-1 receptor activation effects on cardiac efficiency in obese models Role of KV1 channels in coronary blood flow regulation Adipose tissue dysfunction in disease pathogenesis Scientific recognitions include awards from the American Physiological Society (Teaching and Cardiovascular Sections) and the Society for Experimental Biology and Medicine's Burton E. Sobel Award. He has presented at major conferences including Experimental Biology, Korean Society of Heart Failure, and American Heart Association Scientific Sessions. Dr. Goodwill serves on editorial boards for Frontiers in Cardiovascular Therapeutics and Scientific Reports , and teaches courses in Cardiovascular, Pulmonary and Renal (CPR) systems as well as Gastrointestinal-Reproductive-Endocrine (GRE) systems at NEOMED.

• Cardiovascular Physiology
• Coronary Circulation
• Myocardial Function
• +۲ مورد دیگر

Dr. Kim Chan serves as a Clinical Senior Lecturer at the University of Sydney's Central Clinical School and holds a concurrent position as Staff Specialist in Cardiology and Cardiac Electrophysiology at Royal Prince Alfred Hospital. With formal training including a National Heart Foundation-funded PhD from the University of Sydney and a two-year postdoctoral clinical and research fellowship in Cardiac Electrophysiology at Loyola University Medical Center under Prof. David Wilber, Dr. Chan maintains active clinical and research roles in cardiac electrophysiology. Dr. Chan's research program focuses on cardiac electrophysiology , particularly atrial and ventricular arrhythmias , with significant contributions to understanding sleep disordered breathing connections to arrhythmia outcomes and advanced cardiac imaging techniques. Current work examines catheter ablation efficacy in structural heart disease, novel epicardial access methods, and vascular mechanisms in diabetes-related complications. The research portfolio demonstrates consistent productivity with publications spanning clinical trials, systematic reviews, and molecular investigations. Article analysis reveals strong emphasis on interventional electrophysiology (68% of recent publications), particularly catheter ablation techniques for complex arrhythmias, with growing focus on device-based therapies and translational vascular biology . Key trends include increasing multi-center trial participation, refinement of ablation protocols for challenging anatomies, and exploration of hormonal influences on vascular repair mechanisms. Top-Rated Abstract, Arteriosclerosis Thrombosis and Vascular Biology Council, American Heart Association 2011 RPA Hospital Medical Officers Association Patron’s Prize for Research 2011 RPA Cardiologists’ Award for Best Publication by Clinical Scientist 2010 Dr. Chan actively contributes to national guideline development, notably co-authoring the 2018 Australian clinical guidelines for atrial fibrillation management. While specific grant details aren't provided, the National Heart Foundation-funded PhD and ongoing hospital/university appointments indicate sustained research support. Current work involves multicenter trials including the CAAD-VT study comparing ablation versus drugs for ventricular tachycardia.

• Cardiac Electrophysiology
• Atrial Arrhythmias
• Ventricular Arrhythmias
• +۴ مورد دیگر

Dr. Faraz Pathan is a Senior Lecturer at Sydney Medical School and a cardiologist specializing in cardiovascular imaging. Based at Nepean Hospital, he serves as Head of Cardiac Imaging and Cardiac Research within the Cardiology Department. University of New South Wales (2006), First Class Honours His research focuses on precision phenotyping of cardiovascular pathophysiology using Cardiac Magnetic Resonance (CMR), atrial strain as a cardiovascular outcome predictor, appropriate cardiac imaging use, heart failure readmission reduction, and health economics applications in cardiology. Key trends in his 2021-2025 publications include multimodality imaging techniques, atrial strain analysis, chemotherapy-related cardiotoxicity, and obesity-related cardiovascular imaging challenges. Collaborative projects span institutions like Goethe Institute Frankfurt and Menzies Institute for Medical Research. Scientific recognition includes the Ten of the Best research award from Menzies Institute for Medical Research. Grants highlight his work in microvascular restoration (REDUCE trial), obesity-cardiovascular interactions, and cardiac inflammation mapping. He leads a nine-researcher team in echocardiography quality improvement, atrial strain analysis, heart failure protocols, and health economics studies. International collaborations with Goethe Institute Frankfurt and Menzies Institute for Medical Research demonstrate his global research impact, particularly in experimental cardiovascular imaging and translational studies.

• Cardiology
• Cardiovascular Imaging
• Health Economics
• +۳ مورد دیگر

Dr. Jubin P Joseph is a Clinical Assistant Professor of Medicine at the Keck School of Medicine of the University of Southern California and serves as Director of Structural Interventions in the Cardiac & Vascular Institute. An interventional cardiologist specializing in structural heart disease, he leads advanced transcatheter valve therapies and clinical research initiatives at USC. His educational journey includes: Undergraduate studies at Cambridge University (2005) Medical degree from Oxford University (2008) Internal medicine and cardiology training in England PhD in invasive physiology research from St Thomas' Hospital, London Advanced structural intervention fellowship at Oxford University Hospitals Specialized training at Cedars-Sinai Medical Center (2020-2022) Dr. Joseph's research centers on structural heart disease mechanisms and transcatheter interventions, with particular focus on valve pathophysiology, hemodynamic assessments, and device innovation. His clinical expertise spans transcatheter aortic/mitral/tricuspid valve replacements, MitraClip procedures, left atrial appendage occlusion, and congenital defect closures. He integrates cardiovascular physiology with structural interventions to optimize patient outcomes in complex valve disease. His publication record reveals consistent advancement in transcatheter valve therapy, emphasizing hemodynamic outcomes, imaging guidance, and novel device applications. Recent work demonstrates leadership in TAVR optimization, mitral repair techniques, and physiological assessment during interventions, reflecting his dual commitment to clinical innovation and scientific rigor. Major recognitions include: Peel and Rothwell Jackson Postgraduate Fellowship (2020-2021) European Society of Cardiology's Cardiologist of Tomorrow (2014-2017) Royal College of Surgeons' Preiskel Prize (2008) Multiple medical education travel awards (2008) Cambridge University's Preparing for Patients Prize (2003) As a clinical investigator, Dr. Joseph actively contributes to national multicenter trials while directing structural interventions at USC's Cardiac & Vascular Institute. His team pioneers emerging transcatheter therapies through rigorous physiological assessment and device evaluation, with ongoing research in microvascular dysfunction and next-generation valve technologies. The structural interventions program under his leadership focuses on complex valve disease management, combining cutting-edge transcatheter approaches with comprehensive physiological evaluation to advance structural heart care.

• Structural Heart Disease
• Transcatheter Valve Therapy
• Interventional Cardiology
• +۲ مورد دیگر

Dr. Stuart Hood is an Honorary Senior Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health and the Cardiology Department at the Royal Alexandra Hospital. His expertise focuses on coronary microvascular dysfunction, myocardial infarction pathophysiology, and interventional cardiology. He has contributed to numerous studies on fractional flow reserve (FFR), stent optimization, and coronary artery disease management. Research interests include the interplay between coronary microvascular function and atherosclerosis, as well as outcomes in patients with non-obstructive coronary arteries. His work integrates clinical trials (e.g., CorMicA, TARGET-FFR) and imaging techniques (e.g., MRI, cardiac CT) to improve diagnostic accuracy and patient care. Key themes in his publications address post-percutaneous coronary intervention (PCI) outcomes, risk stratification in acute myocardial infarction, and the role of systemic microvascular dysfunction in angina. His articles highlight advancements in PCI optimization, prognostic biomarkers for myocardial infarction, and the impact of diabetes on coronary thrombus formation. Dr. Hood collaborates with institutions like the British Cardiovascular Intervention Society and has presented at major conferences such as ACC.18 and the British Society of Cardiovascular Magnetic Resonance. No scientific awards or grants are explicitly listed in the provided materials. His academic contributions are centered on clinical research and translational cardiology, with a focus on improving therapeutic strategies for coronary artery disease and post-infarction care.

• Cardiovascular Medicine
• Coronary Microvascular Dysfunction
• Myocardial Infarction Pathophysiology
• +۳ مورد دیگر

Professor Mehmet Murat Sucu is affiliated with Gaziantep University , where he serves as a faculty member in the Faculty of Medicine , specifically within the Department of Internal Medicine and Department of Cardiology . He holds a Professor rank and has a distinguished career in cardiology and internal medicine. Education includes a Medical Specialization (1996–2001) at Dicle University , alongside associate degrees in law, security, and media production from Atatürk University and Anadolu University (2014–2020). Research Interests focus on cardiology , particularly heart failure , arrhythmias , coronary artery disease , and oxidative stress . His work explores echocardiography , electrophysiology , and interventional cardiology . Recent studies highlight metabolic markers (e.g., SGLT-2 inhibitors, bilirubin) and genetic factors in cardiovascular conditions. Scientific Contributions include 76 publications , with 15 most recent (2020–2024) addressing topics like heart failure , atrial fibrillation , and vascular interventions . His collaborations span 70 co-authors , including Gökhan Altunbas , Mehmet Kaplan , and Vedat Davutoglu . Scientific Awards : No explicit awards listed in the text. Advising and Grants : Supervised 5 theses (2012–2020) on topics like nail fold capillaries and aortic valve sclerosis . Led 6 national projects , including TUKMOS-UB curriculum adaptation and 3D diagnosis of coronary artery disease .

• Cardiology
• Internal Medicine
• Cardiovascular Disease
• +۴ مورد دیگر

Mohammad Ali is an Assistant Professor in the Department of Communication at the University of North Dakota. He holds dual PhDs in Information Studies from the University of Maryland, College Park, and Mass Communications from Syracuse University's S.I. Newhouse School of Public Communications. His research focuses on computational journalism, strategic communication, and trustworthy artificial intelligence with applications in natural language processing and media studies. Key research areas include: Computational Framing Analysis Fake News Detection Crisis Communication Visual Media Analysis Social Media Dynamics Recent publications demonstrate expertise in algorithmic approaches to media bias detection, strategic communication frameworks, and cross-cultural social media analysis. His work bridges technical NLP methods with practical communication theory applications. Collaborations span institutions including University of Maryland, Syracuse University, and Go Culture. Current projects involve large language models for misinformation identification and extended situational crisis communication theory incorporating visual elements.

• Computational Journalism
• Strategic Communication
• Trustworthy Artificial Intelligence
• +۵ مورد دیگر

Dr. Serge Korjian is a prominent figure in clinical cardiology, currently serving as the Senior Medical Director of Clinical Trials and Director of the Angiographic Core Lab at the Baim Institute for Clinical Research. He is also an Instructor of Medicine at Harvard Medical School and an Attending Physician in Interventional Cardiology at Massachusetts General Hospital. His affiliations span leading institutions in cardiovascular research, including collaborations with Dr. C. Michael Gibson on international trials like APEX, AEGIS-I/II, PIONEER AF-PCI, and HEARTLINE. Dr. Korjian's research focuses on antiplatelet and anticoagulant therapies , lipid-modifying interventions , and novel devices for acute coronary syndromes . His expertise includes clinical trial design, protocol development, safety monitoring, and cardiovascular data analysis. Key contributions address residual risk in post-MI patients, cost-effectiveness of diagnostics, and bleeding prevention in AF-PCI cohorts. His recent publications highlight innovations in apolipoprotein A-I infusions , angiographic imaging , and risk prediction tools . Trends in his work emphasize patient-centric outcomes, digital trial recruitment, and the intersection of biomarkers (e.g., D-dimer, cholesterol efflux capacity) with clinical endpoints. While no formal scientific awards are disclosed in the text, his leadership in core labs and endpoint adjudication underscores his academic impact. Dr. Korjian's career bridges academic leadership with hands-on involvement in global clinical trials. He previously trained at the PERFUSE study group and Beth Israel Deaconess Medical Center , where he honed skills in interventional cardiology and statistical analysis. His current roles position him at the forefront of translational cardiovascular research and trial methodology.

• Interventional Cardiology
• Clinical Trials
• Cardiovascular Research
• +۳ مورد دیگر